Thursday, July 16, 2026
Home Blog Page 468

The Hemp Industry Responds To The DEA Rule With A Lawsuit

Petitioners claim that a recent DEA rule is unlawful because it exceeds the DEA’s authority and violates the 2018 Farm Bill.

On August 21, the Drug Enforcement Agency (the “DEA”) released an Interim Final Rule (the “Rule”), which, in part, suggests that in-process hemp extract shall be treated as a schedule I controlled substance during any point at which its THC concentration exceeds 0.3 percent on a dry weight basis. “Any point” includes even fleetingly during the processing phase and includes situations where the THC percentage is brought back into legal compliance for the finished product.

In response to this threat, close to 2,500 hemp stakeholders have already expressed their opposition to the Rule by submitting comments via the federal public docket. But some have taken their opposition one step further by suing the DEA. On Friday, September 18, the Hemp Industries Association (“HIA”) and RE Botanicals, a South Carolina hemp CBD manufacturer, filed a petition against the DEA and its acting administrator, Timothy Shea, in the U.S. Court of Appeals for the District of Columbia.

The petitioners claim that the Rule is unlawful because it exceeds the DEA’s authority and violates the Agriculture Improvement Act of 2018 (the “2018 Farm Bill”). Specifically, the Rule contradicts the plain language and the intent of the 2018 Farm Bill, which legalized hemp, its derivatives, extracts and cannabinoids so they could be regulated as agricultural commodities, and thus, fall outside the DEA’s jurisdiction.

RELATED: A Bipartisan Bill Would Regulate Hemp CBD As A Dietary Supplement

In addition, HIA and RE Botanicals argue that the DEA failed to issue the Rule in compliance with administrative procedures imposed under the Administrative Procedure Act (the “APA”). Indeed, Mr. Shea implemented the Rule without providing the public with notice and the opportunity to comment before the Rule went into effect. Instead, the Rule provides that its content “merely conforms DEA’s regulations to the statutory amendments to the [Controlled Substances Act] that have already taken effect, and it does not add additional requirements to the regulations.” (Emphasis added).

USDA Releases Hemp Rules
Photo by David Trood/Getty Images

While the Rule clearly suggests that the DEA is exceeding its authority and is attempting an illegal power grab over lawful hemp activities, only time will tell whether the U.S. Court of Appeals for the District of Columbia will be receptive to the petitioners’ arguments. Yet, one thing is certain, the hemp industry is determined to protect the lawful production of hemp that Congress established when it enacted the 2018 Farm Bill.

RELATED: Why The DEA’s Interim Rule On Hemp-Derived Cannabinoids Is Bad For The Industry

Since the enactment of the 2018 Farm Bill, the hemp industry has had to continuously fight state and federal roadblocks to protect its interest and has had to overcome obstacles with which no other legal industry has been confronted. Yet, the industry’s tenacity along with this lawsuit—one of several lawsuits filed by the industry against state and federal regulators—should give the DEA pause as the industry signals that DEA cannot flat-out ignore the legality of hemp.

If you wish to support the industry it this effort, be sure to submit your comments to the DEA by October 20. Also, contact your representatives to convey the need for Congress to clarify the regulatory gap that is at the center of this Rule. As written, it has the potential to destroy or seriously impair the hemp industry.

 is an attorney at Harris Bricken. This article was originally published on the Canna Law Blog and is reposted with permission.

No Long-Term Negative Brain Effects For Older Marijuana Patients

Compared to non-users, data showed no differences in memory, new learning, and reaction time for medical marijuana patients.

Older adults have begun consuming cannabis more than ever, often using the plant to deal with chronic pain. Marijuana use almost doubled among adults ages 65 and older, a study published earlier this year found. In the United States, about 20% of medical cannabis patients are over 60. Contrary to popular belief, a study shows no long-term negative effects for older marijuana patients.

New research out of Israel shows those adults should not expect any ill cognitive differences when compared to non-users. The study, published in the journal Drug & Alcohol Review, also found no disparities between older cannabis users and non-users when testing for cannabis use frequency, doses, years of use, and THC/CBD concentration.

“Moreover, both [medical cannabis] licensed and non-licensed patients performed relatively similar to a standardized population with no chronic pain,” the study’s authors wrote.

RELATED: Study Finds Medical Marijuana Patients Are Happier And Healthier Than Non-Users

For the observational study, Israeli researchers gathered 63 long-term medical users and 62 non-users who all suffered from chronic pain, using cognitive tests to collect data on performances measures, such as reaction time, memory recall, and more.

No significant discrepancies were found between the two groups. Researchers, however, did note that the medical marijuana users were more likely to suffer from cardiovascular disease and depression.

How To Talk About Cannabis With The Elderly
Photo by rawpixel.com

“Considering the accumulating evidence showing efficacy of cannabis use for multiple health conditions common in older individuals, the lack of adverse effects on the brain in the current sample of individuals with chronic pain who were older than 50 years can contribute to a better risk–benefit assessment of [medical cannabis] treatment in this population.”

RELATED: 3 Things Older Adults Using Marijuana Should Be Cautious Of

Previous research indicates medical cannabis can positively impact older adults. Seniors reported higher quality of life in a study published earlier this month. Research this summer also found medical cannabis patients experienced less hospital visits and used fewer medications compared to non-users.

“With greater percentages of seniors both turning to, and returning to, the use of cannabis, it is important that scientists begin to focus greater attention this unique and frequently overlooked group of consumers,” NORML Deputy Director Paul Armentano said in a statement. “We already know that many seniors suffer from ailments that may be effectively treated with cannabis, and this emerging data suggests that they can do so in a manner that poses little if any risk to their cognitive well-being.”

American Progressives Have Ignored Successful Alternatives To The Drug War — Is That About To Change? 

0

Disclaimer: The views expressed in this article solely belong to the author and do not necessarily represent those of The Fresh Toast.

 Progressives have sometimes delayed legalization efforts to dole out lucrative licenses to select members of minorities as a form of “reparations.”  

The cannabis communities (note the plural) were disappointed (again) last week when the Democratic-controlled House of Representatives delayed a vote on the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act until after the elections. Although it is obviously frustrating, the short delay may actually ensure greater success in November. 

As an excellent report on MarijuanaMoment.com pointed out, the bill actually has the support of a majority of the House Republicans, but some moderate House Democrats (an endangered species) were afraid of being mocked by prohibitionists in November.  

“They felt that advancing the reform legislation before passing another coronavirus relief bill looked bad for them—a position that advocates say is nonsensical given the widespread popularity of the issue.” 

As The Grio reported, Last May, “Senate Majority Leader Mitch McConnell took exception to the word “cannabis” appearing more times than the word “jobs” in the $3 trillion coronavirus bill introduced by House Democrats..”  

Of course, marijuana legalization should be seen as a way to make jobs, not just raise tax revenue. 

SEE: Republicans Mock Pelosi’s Statement That Medical Cannabis Is Relevant to the Pandemic Economic Stimulus  

Unfortunately, McConnell did have one point. The pandemic stimulus bill included a requirement for more research on minority-owned and women-owned marijuana companies, what McConnell called “diversity detectives for the cannabis industry.”  

white concrete building under cloudy sky during daytime
Photo by Harold Mendoza via Unsplash

Having ignored the obviously racist origins and enforcement of marijuana prohibition for almost a century, the Progressives have sometimes delayed legalization efforts to dole out lucrative licenses to select members of minorities as a form of “reparations.”  

SEE: Prohibition 2.0 Making a Mess of Marijuana Legalization. Just Get Out of the Way 

To make the politics even more weird, President Trump has actually recognized that having a marijuana question on the ballot increases voter turnout, and that hurts Republicans, who have a long record of opposition to marijuana reform. 

SEE: Is Trump Willing To Lose The Election For Marijuana Prohibition? Even Republicans Support Legalization 

On the other hand, Biden seems to understand the political power of the issue. He is definitely not willing to lose the election for a lost cause, but just can’t quite bring himself to say “Legalize it.”

SEE: Biden Sort Of Decides On Marijuana Legalization: He Is Sort Of Still Against It

Like Biden, his running mate, Kamala Harris, was against marijuana legalization before she was for it. As Forbes reports, “While Harris’ past history on cannabis was certainly not one that suggested advocacy for cannabis reform, she seemed to shift gears rapidly over the last few years.

Marijuana Decriminalization and Record Expungment Top Priority for Biden-Harris Now
Photos: Drew Angerer/Staff/Getty Images; Pool/Pool/Getty Images

Suddenly, she was voicing support for cannabis legalization and even talking about her own experiences with the drug. And it wasn’t just talk, she cosponsored multiple bills aimed at improving things for the cannabis industry, and those impacted by the war on drugs.” 

SEE: Kamala Harris’ Controversial Cannabis History Is Making Waves —Here’s Where She Stands Now 

In any case, the Democrats can at least count the votes, so they are committed to legalization, in one form or another. However, my continuing frustration with our Progressive friends is exemplified in a generally excellent article on the Leftist website Salon.com: 

Want to reform the police? That must start with decriminalizing drugs 

Too much police violence against people of color is justified by a connection to illegal drugs. There’s an easy fix.  

At this stage in the debate do Progressives really need to be told that??? I have often written about this. 

SEE: Don’t Mention The Drug War. We Must Decriminalize Being Black. Black Freedom Matters  

And it will certainly not be a new idea to readers of the Libertarian magazine Reason.com.  

SEE: Want to Reform the Criminal Justice System? End the Drug War 

AND: End the War on Drugs  

American Progressives have long ignored successful alternatives to the Drug War in other countries. For over 40 years the Dutch have allowed the sale of cannabis in their “coffeeshops”. The results: the Dutch annual per capita rate of cannabis use is less than half of the American rate (5.4% vs 13.7%) and the hard drug use rate is even lower (0.3% vs 0.57%). And the murder rate is less than one fifth the U.S. rate.  

What The US Can Learn From Holland’s Coffee Shop Cannabis Model
Photo by Wikimedia user Sissssou

SEE: We Must End Marijuana Prohibition For Economic Recovery In A Post Pandemic World

And for 20 years, Portugal has had a policy of “decriminalization” for all drugs. This policy addresses both the public health problems associated with injecting hard drugs, and conflicts with the police.  

SEE: Drug policy of Portugal  

But for eight years, Barack Obama did nothing to stop the arrests, so opponents of the Drug War often find themselves in a situation reminiscent of James Thurber’s The Peacelike Mongoose and a few other things in contemporary politics:  

“In cobra country a mongoose was born one day who didn’t want to fight cobras or anything else. The word spread from mongoose to mongoose that there was a mongoose who didn’t want to fight cobras. If he didn’t want to fight anything else, it was his own business, but it was the duty of every mongoose to kill cobras or be killed by cobras. 

“”Why?” asked the peacelike mongoose, and the word went around that the strange new mongoose was not only pro-cobra and anti-mongoose but intellectually curious and against the ideals and traditions of mongoosism. 

“He is crazy,” cried the young mongoose’s father.  

“He is sick,” said his mother.  

“He is a coward,” shouted his brothers.  

“He is a mongoosexual,” whispered his sisters. 

Strangers who had never laid eyes on the peacelike mongoose remembered that they had seen him crawling on his stomach, or trying on cobra hoods, or plotting the violent overthrow of Mongoosia.  

“I am trying to use reason and intelligence,” said the strange new mongoose. 

“Reason is six-sevenths of treason,” said one of his neighbors. 

“Intelligence is what the enemy uses,” said another.  

Finally, the rumor spread that the mongoose had venom in his sting, like a cobra, and he was tried, convicted by a show of paws, and condemned to banishment.  

Moral: Ashes to ashes, and clay to clay, if the enemy doesn’t get you your own folks may.  

Richard Cowan is a former NORML National Director and author of All You Need To Know About CBD For Children 

Does Oregon’s Eviction Moratorium Apply To Cannabis Businesses?

In response to COVID-19, an Oregon law prohibits only evictions for non-payment of rent and other charges (late charges, utilities and other service charges or fees). What does this mean for commercial landlords?

In a word, yes.

A lawsuit recently filed in Jackson County, Oregon by a tenant alleges that his landlord has wrongfully evicted him from a warehouse containing 36,000 pounds of hemp, which the plaintiff alleges will be worth $1.5 million when processed, and 500 pounds of trimmed flower with a market value of $175,000. (Marks v. Laminate Tech., Inc., 20CV31971 – email me if you’d like a copy of the complaint). Before discussing the lawsuit, let’s briefly review Oregon’s moratoria on evictions, which we’ve closely watched as we’ve advised both landlords and tenants on their options resulting from the moratoria.

On April 1, Governor Brown signed Executive Order 20-13, which imposed a temporary moratorium on evictions in response to the COVID-19 outbreak. This order followed a prior order (20-11) that imposed a temporary moratorium on residential evictions for nonpayment of rent. In Order 20-13, Governor Brown extended that moratorium to include non-residential tenancies (i.e. commercial tenants). Order 20-13 prohibits commercial landlords from terminating any tenant’s lease and from taking action, judicial or otherwise, relating to non-residential evictions for the nonpayment of rent, late charges, utility charges, or other charges or service fees.

The order contained no carve-out for cannabis businesses — so hemp and marijuana businesses were entitled to the protections of Order 20-13. Notably, Order 20-13 did not apply to the termination of leases for causes other than nonpayment. Since most commercial leases impose a number of other conditions on tenants other than paying rent (e.g. maintaining insurance, refraining from illegal conduct, use restrictions), commercial landlords were not entirely prohibited from terminating a lease or commencing eviction proceedings. But a landlord cannot take such actions on the basis of nonpayment of rent.

Order 20-13 was set to expire on July 1, 2020, and so the Oregon Legislature took up House Bill 4213 (“HB 4213”) in order to extend the moratorium on residential and commercial evictions for nonpayment of rent. Governor Brown signed HB 4213 into law at the end of June.

HB 4213 prohibits residential and commercial evictions until September 30, 2020, due to nonpayment of rent. The law does not forgive past-due payments and gives tenants until March 31, 2021, to make overdue payments, without interest. Importantly and like Order 20-13, the law prohibits only evictions for non-payment of rent and other charges (late charges, utilities and other service charges or fees).

RELATED: The Oregon Fires And Cannabis

The law prohibits the termination of lease through delivery of notice, and prohibits landlords from taking any other action that would interfere with a tenant’s possession or use of a leased premises due to nonpayment of rent. But like Order 20-13, commercial landlords may take actions adverse to the tenancy for reasons other than nonpayment of rent — meaning breaches of the lease other than nonpayment. Like Order 20-1, the law contains no carve-out for cannabis businesses.

green plants on white metal frame
Photo by Richard T via Unsplash

Turning to the Jackson County lawsuit, if the allegations are true it appears the defendants plainly took actions in violation of Order 20-13 and HB 4213. The plaintiff alleges he subleases two warehouses from the defendant for the storage of hemp and related business. Since May 2020, says the plaintiff, defendant has “repeatedly” changed the locks and threatened plaintiff with eviction for nonpayment of rent.

Defendant also, allegedly, threatened in writing to dispose of the 36,500 pounds of hemp if rent was not paid by September 21, 2020 and threatened to change the locks (again) and sell other personal property in the warehouse that belongs to plaintiff. The lawsuit contends that the hemp is worth $1,675,000 and asks for damages not to exceed $2,500,000. (The difference is not clear from the complaint.)

Not surprisingly, the plaintiff filed a motion for a temporary restraining order concurrently with filing the complaint on September 21, 2020. The motion was granted and the Court set an order to show cause on October 1, 2020 why a preliminary injunction should not issue.  So stay tuned.

For more on cannabis leasing issues, see:

Jesse Mondry is an attorney at Harris Bricken and this article was originally published on the Canna Law Blog and was reposted with permission.

The Link Between Cannabis And Autoimmune Diseases

Scientific evidence regarding the role of the endocannabinoid system in the treatment of autoimmune diseases is just emerging, but cannabis seems to be a viable treatment. 

Project CBD defines autoimmune diseases as “diseases in which your body’s defense system triggers an abnormal inflammatory response that causes damage to the body’s own tissues. Many conditions fall into this category, including multiple sclerosis, Crohn’s disease, lupus, and celiac disease.

Symptoms may include fatigue, pain, swelling, fever, nausea, numbness, rashes, or hair loss.” These conditions are widespread with about 20% of the populations suffering from some sort of autoimmune disease, the majority of whom are female.

Researchers behind a 2010 study published in the journal Immunobiology point to the possibilities of cannabis as a viable treatment for autoimmune diseases: “Cannabinoids have been shown to act as potent immunosuppressive and anti-inflammatory agents and have been shown to mediate beneficial effects in a wide range of immune-mediated diseases such as multiple sclerosis, diabetes, septic shock, rheumatoid arthritis, and allergic asthma.” 

chronic fatigue syndrome
Photo by Benjamin Combs via Unsplash

According to neuroscientist Adie Rae, PhD, co-founder of Smart Cannabis, scientific evidence regarding the role of the endocannabinoid system in the treatment of autoimmune diseases is just emerging. “For some autoimmune diseases like Crohn’s disease, there’s very promising and preliminary work.”

Researchers have observed that patients who have Crohn’s disease and use cannabis are less likely to have severe side effects and hospitalizations than those who have Crohn’s disease but do not use cannabis. Clinical trials being conducted in Israel point to a significant reduction in Crohn’s disease symptoms in those who treated their symptoms with cannabis oil compared with those in the placebo group. 

RELATED:  CBD Oil And Its Potential Aa A Psoriasis Treatment

Rae adds that the clinical evidence is not as far along for other autoimmune diseases. Researchers have been able to observe that the endocannabinoid system of a patient with fibromyalgia does not function as well as a patient without this disease. While patients with fibromyalgia report improvements when using cannabis, this reporting remains largely anecdotal. 

Without proven scientific research, cannabis patients and their caregivers learn how to use the products and delivery methods that are the most supportive of that individual’s lifestyles and goals. For example, patients who are in chronic pain need help sleeping. So the best kind of products for them are often products that can be ingested orally and last for 6 to 8 hours. 

RELATED: Everything You Need To Know About Your Endocannabinoid System

This long duration allows them enough relief form pain that they can get to sleep and stay asleep. While those on disability can continue taking cannabis orally during the day, many patients need to go to work. So, during those times, when they need to be productive, they need to consume a cannabis product that has a lower THC potency and a shorter duration. 

Personalized Treatment: The Future Of Medical Cannabis
Photo by seksan Mongkhonkhamsao/Getty Images

Even when U.S. based researchers can observe a connection between cannabis and a particular autoimmune disease like fibromyalgia, they are unable to conduct clinical trials at this present juncture due to cannabis’ ongoing classification as a schedule 1 drug. Rae observes, “We need research from the cellular molecular mechanisms up to Phase III clinical trails in order to determine which cannabis at which doses, how many times per day, and in which patients will produce results.” 

Without this scientific data, researchers cannot ascertain with clinical accuracy the best types of cannabis or delivery methods for treating various autoimmune diseases. Rae opines, “This is why we need for the US barriers to research to be eliminated because those are exactly the kinds of questions the patients, doctors, the FDA, and the investigators themselves want the answers to.”

3 Things To Know About A Second Stimulus Check

0

Want to know if a second stimulus check is on the way? How much you could be getting? And when? Here’s what you need to know.

As many Americans struggle to figure out how they’re going to pay their bills next month, stimulus checks are on top of mind. Specifically, are we getting a second one? And if so, how much will it be for?

The good news is we seem to be closer to another stimulus check hitting the mail. On Thursday, Treasury Secretary Steven Mnuchin said he and House Speaker Nancy Pelosi are going to restart stalled talks focused on a second stimulus check and other relief bill measures. Along with Pelosi’s plan for a smaller COVID-19 relief bill, this is a good sign that the House could vote on the proposal as early as October 2.

CNET compiled a list of some of the most important things you need to know about what a second check could look like for those who are eligible. Here are the top three:

IRS could speed up the process for second checks

The first round of stimulus checks took nearly three weeks to send out, but Mnuchin says once legislation is signed, that process could go quicker. “I could get out 50 million payments really quickly,” and start making payments a week after a bill is signed, Mnuchin said in August.

RELATED: Did Marijuana Users Spend Their Stimulus Checks On Weed?

Did Marijuana Users Spend Their Stimulus Checks On Weed Purchases?
Photo by Alexander Mils via Unsplash

Eligibility rules could change (to your advantage)

CNET believes a second stimulus check would largely follow the same guidelines as the first, however, they report that eligibility requirements could change. “It might even benefit your family, if a new stimulus bill redefines who counts as a qualifying dependent.”

Other notes on eligibility, according to CNET:

You’ll probably receive your money quicker with direct deposit

According to the most recent numbers, this is how the nearly 160 million first stimulus payments break down:

  • Direct deposit: 75% or 120 million payments
  • Paper check: 22% or 35 million payments
  • Prepaid EIP debit card: 3% or 4 million payments

What does this mean? You’ll likely receive your next chunk of money faster if you have direct deposit. If you haven’t already registered for direct deposit, here’s how you can do that.

Head over to CNET to glean other important facts about a second stimulus check, including how much you are likely to get.

Kate Middleton Has Been Breaking This Royal Rule For Years

Royal dress code tends to prefer natural-looking polish, if any at all. Yet, the Duchess of Cambridge has managed to sneak in some bright colors over the years without anyone really noticing.

Meghan Markle has made a name for herself as a rule breaker, whether it’s wearing a messy bun or skipping nylons with a dress, but unlike the Duchess of Sussex, Kate Middleton has been pretty strait-laced. That is, until now. Kate Middleton has been breaking this royal rule for years!

Word on the street is that the Duchess of Cambridge has been getting away with….wearing bright nail polish!!! And not just recently, but for basically the entire time she’s been a royal.

This may not seem like a bid deal, but royal dress code tends to prefer natural-looking polish, if any at all. Even the Queen has been wearing this $9 nail polish color for nearly 30 years.

That’s why it was newsworthy when Meghan showed up to the British Fashion Awards in 2018 with dark polish gracing her mom-to-be hands.

https://www.instagram.com/p/BrPy0hzFxJa/

But according to experts, nail color is less about protocol and more about knowing your audience.

“There’s no actual protocol about dark nail polish,” royal correspondent Omid Scobie told BAZAAR.com. “It’s simply about being appropriate—we’d never see this at a royal engagement. [The British Fashion Awards ceremony] is a celebration of fashion and there’s a lot more flexibility on what one can wear.”

RELATED: Meghan Markle And Prince Harry Broke Royal Protocol In The Most Eye-Roll Inducing Way

As Reader’s Digest points out, Kate wore a light pink shade during her wedding ceremony, mixing Bourjois Rose Lounge and Essie Allure to create an original hue. But just because it’s all business in the front, doesn’t mean there’s not a party happening elsewhere. Turns out, Kate’s been wearing colored polish on her toes.

https://www.instagram.com/p/BEtYoLipjqs/

Photo by Michael Steele/Staff/Getty Images

If you look closely at your Instagram feed (we know you follow all of the royal accounts!!), you’ll see that Kate has actually stepped out a few times with bold toes. Really, anytime she’s photographed wearing open-toed shoes.

RELATED: Here’s One Thing You’ll Never See A British Royal Do

https://www.instagram.com/p/BFWQXgkpjly/

In May 2012, as BAZAAR.com reports, Kate attended a dinner hosted by The Thirty Club in London. “She wore a cream gown with a leg slit and sparkly metallic platform sandals. She might’ve opted for natural nails on her fingers, but on her toes, she sported a dark polish.” And she didn’t stop there. Days later, she wore the same shade to a concert at Royal Albert Hall celebrating the 2012 Summer Olympics. Who’s the rule breaker now?

This Is How Millennials Prefer To Consume Their Cannabis

New data breaks down how millennials are spending their money on cannabis. The majority (nearly two-thirds) prefer to consume their weed in this form.

A new report from analytics company Headset found millennials to be the biggest category for cannabis consumption in California and their overwhelming choice for form factor is smoking. The latest report on August sales read, “Millennial Males contributed to the most sales with 37.5% of the market share.” Millennials in general spent 43% of their money on flower, 9% on pre-rolls, and another 23% on vape pens. Making almost two-thirds of all purchases in the inhalant category.

Female cannabis consumers in this category weren’t as big of fans of the smokable categories. Millennial females spent 17% of their money on vape pens in California, which was far less than the men. However, this was the biggest category for female vape pen buyers. Other female age groups spent much less on vape pens.

Top Five Vape Pens

Among all demographics, these were the top five vape pens sold in California for August:

  1. Stiizy
  2. Raw Garden
  3. Heavy Hitters
  4. ABX
  5. Select

“The most notable difference between these brands is that the Gen Z and Millennial age groups contribute an enormous proportion of sales to the top two brands, STIIIZY and Raw Garden. Because Millennials drive the majority of Vapor Pen sales and Gen Z has the strongest over-index of any age groups to vapes, Vapor Pen brands targeting these groups could potentially see strong sales.

RELATED: Millennials Are Fueling The Cannabis Economy

While Heavy Hitters and ABX, ranking 3 and 4 respectively, under-index to Gen Z and Millennials, they are still successful brands in the California vape market and have strong over-indexes to both Gen X and Baby Boomers. This shows that even within a category, there are brands that resonate best with different types of customers.”

Study: Women Are More Disgusted By Sex Than Men
Photo by rawpixel.com

Washington

The August sales report also took a deep dive into the state of Washington as a comparison. Men also dominated the smokable categories in this state as well. Over 60% of the sales in the flower and vape categories were by men. 59% of pre-roll sales were also men.

RELATED: Here’s How Millennials And Boomers Differ On Marijuana Use

Women in this market prefer edibles. They make up 35% of the total cannabis market in the state, but when it comes to edibles, they account for 43% of the sales. Here are the top ten edible products in Washington according to Headset:

Top Ten Edibles

  1. Magic Kitchen
  2. Hot Sugar
  3. Craft Elixirs
  4. Verdelux
  5. FlavRX
  6. CannaBurst
  7. The 4.20 bar
  8. Honu
  9. Mr. Moxey’s Mints
  10. Smokiez

This article originally appeared on Green Market Report and has been reposted with permission.

Does Demi Lovato Smoke Weed?

Demi Lovato is making headlines for ending her (very short) engagement. Is she turning to weed to help her cope with her quarantine breakup?

Demi Lovato is one of Disney’s biggest success stories. She kicked off her career by acting and singing along with the Jonas Brothers. Afterwards she focused on her music career, releasing tons of Billboard hits. Lovato is also a spokesperson for LGBTQ rights, bullying, eating disorders, and her own personal experiences with addiction.

This week, Lovato has been trending in the news due to her breakup with actor Max Ehrich. The couple got engaged just five months after meeting in quarantine.

Lovato may not be the best at embracing red flags, but what about the green?

RELATED: Does Will Smith Smoke Weed?

Lovato has struggled with addiction from a young age, making her relationship with drugs a very complicated one. In 2015, Joe Jonas said in an interview that the first time he smoked weed, he was peer pressured by Lovato and Miley Cyrus. During 420 of the same year, Lovato uploaded a photo to Instagram of the three of them with the caption: “In honor of our former escapades, I thought you’d like this to remember our first blaze…Happy #420.”

Demi Lovato Tom Cruise Jamie Foxx
Photo by Jason Merritt/Staff/Getty Images

Some years later, when Cyrus decided to quit marijuana and alcohol, Lovato made a statement in her support, telling The Hollywood Reporter, “I am really proud of Miley. I think that it helps people to know that there are people in the spotlight that have challenges, that are faced with very stressful lives. I think it helps to know that recovery is possible and it’s something that is so important to certain people like myself.”

RELATED: How Miley Cyrus Convinced Her Mom To Start Smoking Weed

While she commends those who choose to steer clear of drugs, she supports people doing whatever it is they want to do. When singer Lauren Jauregui uploaded a photo of herself with a joint, her fans were outraged, with many commenting on her behavior. Lovato was quick to show her support via Instagram. “Y’all stop telling her what to do and what not to do. Girl live your life.”

Sobriety means different things to different people. While some choose to avoid substances altogether, others are able to consume marijuana and steer clear of other substances that are more harmful and that could encourage a relapse. In the case of Lovato, there’s no way of knowing unless she explains it herself.

Federal Courts Are Going Backward On Cannabis

In 2020, state courts still seem to be a good bet for cannabis businesses in cannabis-legal states. But federal courts are sliding backward.

A few weeks back, the Cannabis Law Institute invited me to discuss contract drafting for cannabis deals. A focal point for the panel was whether courts are willing to enforce cannabis contracts. The last time I had really looked at that issue was early 2019, when I wrote: Cannabis Dispute? Courts are Open. As the title indicates, my research (and our law firm’s experience) showed that both state and federal courts were generally open to resolving cannabis contract disputes at the time. And I assumed the trend had held. Unfortunately, it has not!

In the 2019 piece, I summarized:

[Contract enforceability] was always the biggest consideration in choosing a forum for cannabis disputes. A few months ago, we ran a survey of federal courts and cannabis litigation, observing that none of the districts at issue were invalidating state-sanctioned businesses’ cannabis contracts on the dreaded “illegal purpose” basis. This trend is holding strong in recent federal court disputes on issues from RICO to patent infringement, despite the prohibited status of “marijuana” under federal law. As to state courts, the decisions declining to hear cannabis beefs are pretty far in the rearview. (Ironically, it has been safer overall to enforce cannabis contracts in federal courts that state courts to date.) When drafting agreements for cannabis clients, we still advise as to the diminishing possibility of non-enforcement, but most cannabis companies seem comfortable choosing court over arbitration if other goals are satisfied.

In 2020, state courts still seem to be a good bet for cannabis businesses in cannabis-legal states. Although I have not run a formal survey, I also have not come across local courts tossing disputes solely because the contract related to cannabis activities (and our cannabis business litigators have worked on many of these cases). But federal courts are sliding backward. A trio of cases in Washington, Oregon and Nevada show why.

RELATED: Kamala Harris Will Help With Cannabis Reform (And That’s Good Enough For Me)

Before running that dismal gauntlet, it’s important to understand the rationale used by federal courts to enforce cannabis contracts previously. The touchstone ruling here is found in Mann v. Gullickson, 2016 WL 6473215 (N.D. Cal. Nov. 2, 2016). In that case, the court observed that “[n]o principle of law is better settled than that a party to an illegal contract cannot come into a court of law and ask to have his illegal objects carried out…” (quoting Wong v. Tenneco, Inc., 39 Cal. 3d 126, 135 (1985)). That makes sense, right? For example, if Party A pays Party B to start a forest fire, but Party B pockets the cash and skips town, no court would require Party B to return and start the fires. The contract would be void for public policy reasons.

But there’s some wiggle room here. The Mann court also observed that “[e]ven where contracts concern illegal objects, where it is possible for a court to enforce a contract in a way that does not require illegal conduct, the court is not barred from according such relief.” As such, the court determined it could require a cannabis company borrower to repay a loan it had received (provided the case did not settle between summary judgment and trial). Requiring someone to repay a loan, after all, doesn’t require the debtor to violate any laws– even if the debtor is a scofflaw.

In legal terms, what the Mann court did is “sever” the narrow, kosher contract requirements from the broader, “illegal contract” at issue. This is in keeping with our early 2019 survey of the federal courts, mentioned above. Specifically, we concluded in that blog post that courts were “find[ing] ways around invalidating contracts simply because they happen to involve cannabis–and sometimes even when they include terms that require parties to violate federal law–so long as those provisions are severable.”

RELATED: The Oregon Fires And Cannabis

Unfortunately, courts seem to be rethinking this approach, not just in jurisdictions that comprise states without legal cannabis programs, but in states that have taken the lead on ending prohibition. Below are the 2020 decisions in Washington, Oregon and Nevada, which show courts backing up a bit.

Bart St. III v. ACC Enterprises, LLC, No. 217CV00083GMNVCF, 2020 WL 1638329 (D. Nev. Apr. 1, 2020)

Like MannBart St. is a loan default case. Plaintiff lent defendant, a cannabis grower, $4.7 million under a contract governed by Nevada law. When the defendant defaulted, plaintiff sued for breach of contract and unjust enrichment. Defendant argued that it couldn’t be liable for breach of contract: under federal law, the contract was illegal. The judge agreed as to various portions of the contract, but could not decide on summary judgment whether the illegal provisions could be severed from the rest of the agreement. For that reason, the defendant’s summary judgment motion was denied on the breach of contract claim. As to the unjust enrichment claim, the judge wrote:

Plaintiff cannot prevail for unjust enrichment because the parties’ contract involves moral turpitude. If the Contract is unenforceable, it is because Plaintiff invested in Defendants’ marijuana cultivation business primarily to obtain a pathway to an equity investment therein . . . . Providing funds in exchange for equity violates the CSA because it would allow the investor to profit from the cultivation, possession, and sale of marijuana . . . . Conspiracy to cultivate marijuana is a crime of moral turpitude.

Ouch. After that ruling, the defendant was left with one arrow in its quiver (breach of contract). It seems the court will stick to the Mann severability analysis there, but the denial of plaintiff’s equitable claims on an “illegal contract” and/or “moral turpitude” finding, is a discouraging setback.

New Jersey Businesses Can't Fire Medical Marijuana Users, Court Rules
Photo by qimono via Pixabay

Polk v. Gontmakher, No. 2:18-CV-01434-RAJ, 2020 WL 2572536 (W.D. Wash. May 21, 2020)

This one looks like a classic cannabis partnership dispute, complete with regulatory scheming. Polk and Gontmakher owned a company that owned a retail store and a processing facility. When Polk prepared to leave the business, Gontmakher refused to acknowledge his ownership interest: Polk had a prior criminal record, which would have made him ineligible under Washington administrative rules. So Polk sued Gontmakher for breaching their (oral) agreement and to recover past and future profits from the enterprise. Here’s what the Court said, in granting Gontmakher’s motion to dismiss:

Mr. Polk’s claim that his requested relief would not require a violation of the CSA defies logic. He is demanding the future profits of a business that produces and processes marijuana in violation of federal law. How does Mr. Polk anticipate [the business] will generate these future profits? The Court cannot fathom how ordering [Gontmakher] to turn over the future profits of a marijuana business would not require them to violate the CSA. And as this Court has previously explained to Mr. Polk, it cannot award him an equitable interest in [the business] because to do so would directly contravene federal law.

Does that seem unfair to you? It is! It’s also a straightforward reading of the law.

Lilly, LLC v. Clearspan Fabric Structures Int’l, Inc., No. 3:18-CV-01104-HZ, 2020 WL 1855190 (D. Or. Apr. 13, 2020)

To me, this is the scariest one of the three. Unlike the other two cases, the defendant here didn’t even raise the “illegal purpose” defense. The judge just brought it up on his own, sua sponte, and now the parties are stuck with it.

In this matter, J. Lilly, an Oregon licensed cannabis producer, contracted with Clearspan to build its facility and lease some greenhouse equipment. After construction began, J. Lilly gave notice that defects in the facility were impeding cultivation efforts, and ultimately sued for breach of the agreements. J. Lilly claimed lost profits due to the inability to cultivate cannabis. Clearspan moved to dismiss the claims on the basis that the cultivator waived any contractual right to consequential damages– not because the contract had an “illegal purpose.” However, Judge Hernandez raised the issue on his own at oral argument, asked the parties for supplemental briefing, and ultimately held that:

awarding Plaintiff damages for lost profits [for the sale of cannabis] would require the Court to compel Defendants to violate the [CSA…and] provides an independent basis to dismiss Plaintiff’s lost profits claim in addition to [the issue of waiver, and other merits issues.]

Obviously, that’s another tough one for the industry. And it’s especially discouraging that the judge took it upon himself to raise this thorny issue to dispose of the case.

So what are the takeaways here?

  1. Federal courts in 2020 look less inviting than before for cannabis business disputes. That is even (especially?) true in certain cannabis friendly jurisdictions. It seems true in less friendly jurisdictions, too.
  2. The Mann analysis is still viable; courts will continue to grapple with it; and courts may be willing to carve out cannabis contract remedies. But that is true only for certain causes of action, and only if the remedy does not contemplate federally unlawful conduct.
  3. Skillful contract drafting is terribly important. “Severability” clauses, for example, are generally considered boilerplate, but in the cannabis contract context they can be paramount.
  4. As always, federal law has to change. Cannabis is legal for adult use in 11 states and for medical use in 33 states, yet no one has any contract certainty. None of this makes any sense.

We will keep you posted on further developments in this nettlesome area. Until then, for more insight on cannabis contracts in federal court, check out the following blog posts:

Vince Sliwoski is an attorney at Harris Bricken, a law firm with lawyers in Seattle, Portland, Los Angeles, San Francisco, Barcelona, and Beijing. This story was originally published on the Canna Law Blog and has been reposted with permission.

Don't Miss Your Weekly Dose of The Fresh Toast.

Stay informed with exclusive news briefs delivered directly to your inbox every Friday.

We respect your privacy. Unsubscribe anytime.